We found that the levels of metabolites such as inosine and nicotinamide were significantly higher in subjects with NAFLD having elevation of ALT than those in subjects without NAFLD having elevation of ALT. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.